Scoop has an Ethical Paywall
Licence needed for work use Learn More
 

ACN Newswire - Latest News [Page 13]

GMG Signs THERMAL-XR(R) Distributor Agreements In 4 Asian Countries

Thursday, 25 May 2023, 10:04 am | ACN Newswire

BRISBANE, AUS, May 24, 2023 - (ACN Newswire) - Graphene Manufacturing Group Ltd. (TSXV: GMG) ("GMG" or the "Company") is pleased to announce that GMG has signed distribution agreements with four separate distributors ("Distributors") ... More >>

New Access Accelerated Global Collective Report Charts Path Forward In Fight Against Noncommunicable Diseases

Thursday, 25 May 2023, 7:30 am | ACN Newswire

Access Accelerated, a pioneering collective of leading biopharmaceutical and life science companies dedicated to confronting the growing global noncommunicable disease (NCD) crisis, announced the release of a six-year report: Key Lessons in Advancing ... More >>

Machine Intelligence For Designing Molecules And Reaction Pathways

Wednesday, 24 May 2023, 5:56 pm | ACN Newswire

Two key challenges in chemistry innovation are solved simultaneously by exploring chemical opportunities with artificial intelligence. TSUKUBA, Japan, May 24, 2023 - (ACN Newswire) - Researchers in Japan have developed a machine learning process ... More >>

Taiwan Excellence Debuts At ATxSG 2023 With Award-Winning Tech Solutions

Wednesday, 24 May 2023, 5:55 pm | ACN Newswire

SINGAPORE, May 24, 2023 - (ACN Newswire) - Taiwan Excellence, an award-winning entity established by the Bureau of Foreign Trade and the Taiwan External Trade Development Council (TAITRA), makes its debut at this year's Asia Tech x Singapore (ATxSG) Conference ... More >>

Eisai Submits Marketing Authorization Application For Lecanemab As Treatment For Early Alzheimer's Disease In G Britain

Tuesday, 23 May 2023, 3:57 pm | ACN Newswire

TOKYO, May 20, 2023 - (JCN Newswire) - Eisai Co., Ltd. and Biogen Inc. announced today that Eisai has submitted a Marketing Authorization Application (MAA) for lecanemab, an investigational anti-amyloid beta (A) protofibril antibody, for the treatment ... More >>

Neurimmune: Promising Phase 1 Results For Antibody NI006 In ATTR Cardiomyopathy

Tuesday, 23 May 2023, 3:52 pm | ACN Newswire

Results also presented during late-breaking session at ESC Heart Failure congress 2023 ZURICH, SWITZERLAND, May 22, 2023 - (ACN Newswire) - Neurimmune announced today that primary results of its Phase 1 proof-of-concept study of NI006, a recombinant ... More >>

Degen Announces Release Of Rocketcoin

Tuesday, 23 May 2023, 12:04 pm | ACN Newswire

A new meme coin frenzy has been all set to roll-out in May where we shall see a 0 Tax trading token making headlines in the meme space in the crypto market. Lauded primarily for its no stealth launch and allowing equal opportunity to all investors ... More >>

Trenton Systems And Graid Technology Partner To Deliver Cutting-Edge HPC Solutions

Saturday, 20 May 2023, 10:13 pm | ACN Newswire

Trenton Systems and Graid Technology Partner to Deliver Cutting-Edge HPC Solutions for Mission-Critical Sea, Land, Air, Space, & Cyberspace Applications Trenton Systems now offers SupremeRAID(TM) GPU-based NVMe RAID controller, enabling maximum ... More >>

Taiwan's First Heavy Ion Therapy System Starts Treatment At Taipei Veterans General Hospital

Saturday, 20 May 2023, 9:59 pm | ACN Newswire

Hitachi's First Heavy Ion System outside of Japan TOKYO, May 18, 2023 - (JCN Newswire) - Hitachi, Ltd. (TSE:6501) announced today that it has delivered a heavy ion therapy system to Taipei Veterans General Hospital and the system has started treatment as ... More >>

Fertilix Effective In Blocking Damage From Low-Dose Exposure To Chemicals Commonly Found In Plastic Consumer Products

Saturday, 20 May 2023, 9:57 pm | ACN Newswire

CLERMONT-FERRAND, FRANCE, May 19, 2023 - (ACN Newswire) - According to a recent study by Universite Clermont Auvergne researchers, exposure to chemical additives and building blocks commonly used in everyday plastic products, even in low doses, ... More >>

2023 World Culture Festival: Preliminary Lineup Announced

Saturday, 20 May 2023, 9:53 pm | ACN Newswire

World leaders, >1,000 artists & entertainers to participate in the Olympic-scale celebration alongside an expansive list of interfaith spiritual leaders. Washington, DC, May 19, 2023 - (ACN Newswire) - Today, District of Columbia Mayor ... More >>

CitaDAO Successfully Completes Real Estate Tokenisation, Shaping The Future Of Real Estate Ecosystem

Saturday, 20 May 2023, 6:07 pm | ACN Newswire

SINGAPORE, May 19, 2023 - (ACN Newswire) - In a notable step forward, CitaDAO is delighted to share the successful completion of its third Introducing Real Estate On-Chain (IRO) project. This achievement, the tokenisation of a prime industrial ... More >>

Namogoo & Persado: Partnership Leveraging Intent Prediction & Generative AI For Real-Time Shopping Personalization

Thursday, 18 May 2023, 3:30 pm | ACN Newswire

The two companies join forces to analyze visitors' intent in real-time and personalize language and tone of voice for online shoppers as they browse - at scale Herzliya, Israel, May 17, 2023 - (ACN Newswire) - Namogoo, the leading Digital Journey Continuity ... More >>

GMG Announces Battery Joint Development Agreement With Rio Tinto

Thursday, 18 May 2023, 3:25 pm | ACN Newswire

BRISBANE, AUS, May 17, 2023 - (ACN Newswire) - Graphene Manufacturing Group Ltd. (TSXV: GMG) ("GMG" or the "Company") is pleased to announce that GMG and Rio Tinto have signed a binding Joint Development Agreement ("JDA") ... More >>

Asia Summit On Global Health Gathers 90+ Global Elites

Thursday, 18 May 2023, 3:21 pm | ACN Newswire

Hong Kong International Medical and Healthcare Fair showcases state-of the-art healthcare solutions from 300 exhibitors HONG KONG, May 17, 2023 - (ACN Newswire) - The second International Healthcare Week (IHW), organised by the Hong Kong Trade Development ... More >>

ZeptoMetrix Launches PROtrol: Quality Control Material For The Lateral Flow Immunoassay Market

Wednesday, 17 May 2023, 7:08 am | ACN Newswire

ZeptoMetrix(R) is excited to introduce PROtrol(TM), a new line of products designed for antigen-based diagnostic methods. These third-party materials mimic a true clinical specimen and can be used to evaluate and monitor the performance of antigen-based ... More >>

SAVIC Inc. Empowers Qnovate Inc. With SAP S/4HANA Public Cloud For Unleashing Digital Transformation

Tuesday, 16 May 2023, 3:06 pm | ACN Newswire

TAMPA, FLA., May 16, 2023 - (ACN Newswire) - SAVIC Inc., a leading implementation partner, is thrilled to announce the successful implementation of Rise with SAP Public Cloud for Qnovate Inc., a prominent technology solutions provider. This collaboration ... More >>

HKTDC And Dun & Bradstreet Hong Kong Join Forces To Help SMEs Enhance ESG Competitiveness

Tuesday, 16 May 2023, 2:54 pm | ACN Newswire

HONG KONG, May 15, 2023 - (ACN Newswire) - The Hong Kong Trade Development Council (HKTDC) and Dun & Bradstreet (HK) Limited (D&B) announced a new partnership to help small and medium-sized enterprises ("SMEs"), start-ups, and Micro-, ... More >>

2023 CAP Consumer Surveys Continue To Show The Benefits Of Effective Site Blocking

Tuesday, 16 May 2023, 2:44 pm | ACN Newswire

Singapore, May 15, 2023 - (ACN Newswire) - The most recent piracy landscape consumer surveys commissioned by the Coalition Against Piracy (CAP) show that while piracy rates remain stable in many countries around Asia-Pacific, we have seen notable increases ... More >>

Palladium One Announces Exercise Of Anti-Dilution Right By Strategic Shareholder

Tuesday, 16 May 2023, 7:52 am | ACN Newswire

Palladium One Mining (TSXV: PDM) (FSE: 7N11) (OTCQB: NKORF) ("Palladium One" or the "Company") is pleased to announce that Glencore plc ("Glencore"), a large shareholder of the Company through its wholly-owned subsidiary, has elected ... More >>

   

 
 
 
 
 

LATEST HEADLINES

  • PARLIAMENT
  • POLITICS
  • REGIONAL
 

Join Our Free Newsletter

Subscribe to Scoop’s 'The Catch Up' our free weekly newsletter sent to your inbox every Monday with stories from across our network.